#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1. Introduction
1-1	0-2	1.	_	_	_	_
1-2	3-15	Introduction	abstract	new	_	_

#Text=Finding critical in vitro and/or in silico parameters ( descriptors or properties ) of the hit→lead→seed→drug route is still a long-term aspiration and monumental challenge in drug discovery projects , mainly due to the intrinsic multidimensionality of the problem .
2-1	16-23	Finding	_	_	_	_
2-2	24-32	critical	_	_	_	_
2-3	33-35	in	_	_	_	_
2-4	36-41	vitro	_	_	_	_
2-5	42-48	and/or	_	_	_	_
2-6	49-51	in	_	_	_	_
2-7	52-58	silico	event|abstract[3]	new|new[3]	coref|coref	15-30|15-30
2-8	59-69	parameters	abstract[3]	new[3]	_	_
2-9	70-71	(	_	_	_	_
2-10	72-83	descriptors	abstract	new	coref	13-24[124_0]
2-11	84-86	or	_	_	_	_
2-12	87-97	properties	abstract[5]	new[5]	coref	3-39[25_5]
2-13	98-99	)	abstract[5]	new[5]	_	_
2-14	100-102	of	abstract[5]	new[5]	_	_
2-15	103-106	the	abstract[5]|abstract[6]	new[5]|new[6]	_	_
2-16	107-125	hit→lead→seed→drug	abstract[5]|abstract[6]	new[5]|new[6]	_	_
2-17	126-131	route	abstract[5]|abstract[6]	new[5]|new[6]	_	_
2-18	132-134	is	_	_	_	_
2-19	135-140	still	abstract[7]	new[7]	_	_
2-20	141-142	a	abstract[7]	new[7]	_	_
2-21	143-152	long-term	abstract[7]	new[7]	_	_
2-22	153-163	aspiration	abstract[7]	new[7]	_	_
2-23	164-167	and	_	_	_	_
2-24	168-178	monumental	abstract[8]	new[8]	_	_
2-25	179-188	challenge	abstract[8]	new[8]	_	_
2-26	189-191	in	abstract[8]	new[8]	_	_
2-27	192-196	drug	abstract[8]|substance|abstract[11]	new[8]|new|new[11]	coref|coref|coref|coref	14-8|15-46[156_11]|14-8|15-46[156_11]
2-28	197-206	discovery	abstract[8]|abstract|abstract[11]	new[8]|new|new[11]	coref	15-47
2-29	207-215	projects	abstract[8]|abstract[11]	new[8]|new[11]	_	_
2-30	216-217	,	_	_	_	_
2-31	218-224	mainly	_	_	_	_
2-32	225-228	due	_	_	_	_
2-33	229-231	to	_	_	_	_
2-34	232-235	the	abstract[12]	new[12]	_	_
2-35	236-245	intrinsic	abstract[12]	new[12]	_	_
2-36	246-265	multidimensionality	abstract[12]	new[12]	_	_
2-37	266-268	of	abstract[12]	new[12]	_	_
2-38	269-272	the	abstract[12]|abstract[13]	new[12]|new[13]	_	_
2-39	273-280	problem	abstract[12]|abstract[13]	new[12]|new[13]	_	_
2-40	281-282	.	_	_	_	_

#Text=In concert with the medicinal chemist ’s intuition ( or serendipity ) , the computer-assisted molecular design ( CAMD ) approaches are regarded as an integral method for the exhaustive transformation of the compound topology or topography and/or the electronic properties into the property-based chemical space .
3-1	283-285	In	_	_	_	_
3-2	286-293	concert	event[14]	new[14]	_	_
3-3	294-298	with	event[14]	new[14]	_	_
3-4	299-302	the	event[14]|abstract[16]	new[14]|new[16]	_	_
3-5	303-312	medicinal	event[14]|person[15]|abstract[16]	new[14]|new[15]|new[16]	_	_
3-6	313-320	chemist	event[14]|person[15]|abstract[16]	new[14]|new[15]|new[16]	_	_
3-7	321-323	’s	event[14]|person[15]|abstract[16]	new[14]|new[15]|new[16]	_	_
3-8	324-333	intuition	event[14]|abstract[16]	new[14]|new[16]	_	_
3-9	334-335	(	event[14]	new[14]	_	_
3-10	336-338	or	event[14]	new[14]	_	_
3-11	339-350	serendipity	event[14]|abstract	new[14]|new	_	_
3-12	351-352	)	event[14]	new[14]	_	_
3-13	353-354	,	_	_	_	_
3-14	355-358	the	abstract[19]	new[19]	appos	3-19[0_19]
3-15	359-376	computer-assisted	abstract[19]	new[19]	_	_
3-16	377-386	molecular	abstract|abstract[19]	new|new[19]	_	_
3-17	387-393	design	abstract[19]	new[19]	_	_
3-18	394-395	(	_	_	_	_
3-19	396-400	CAMD	abstract	giv	_	_
3-20	401-402	)	_	_	_	_
3-21	403-413	approaches	abstract	new	_	_
3-22	414-417	are	_	_	_	_
3-23	418-426	regarded	_	_	_	_
3-24	427-429	as	_	_	_	_
3-25	430-432	an	_	_	_	_
3-26	433-441	integral	_	_	_	_
3-27	442-448	method	_	_	_	_
3-28	449-452	for	_	_	_	_
3-29	453-456	the	abstract[22]	new[22]	_	_
3-30	457-467	exhaustive	abstract[22]	new[22]	_	_
3-31	468-482	transformation	abstract[22]	new[22]	_	_
3-32	483-485	of	abstract[22]	new[22]	_	_
3-33	486-489	the	abstract[22]|abstract[23]	new[22]|new[23]	_	_
3-34	490-498	compound	abstract[22]|abstract[23]	new[22]|new[23]	_	_
3-35	499-507	topology	abstract[22]|abstract[23]	new[22]|new[23]	_	_
3-36	508-510	or	abstract[22]	new[22]	_	_
3-37	511-521	topography	abstract[22]|abstract[24]	new[22]|new[24]	_	_
3-38	522-528	and/or	abstract[22]|abstract[24]	new[22]|new[24]	_	_
3-39	529-532	the	abstract[22]|abstract[24]|abstract[25]	new[22]|new[24]|giv[25]	coref	14-9[133_25]
3-40	533-543	electronic	abstract[22]|abstract[24]|abstract[25]	new[22]|new[24]|giv[25]	_	_
3-41	544-554	properties	abstract[22]|abstract[24]|abstract[25]	new[22]|new[24]|giv[25]	_	_
3-42	555-559	into	abstract[22]|abstract[24]|abstract[25]	new[22]|new[24]|giv[25]	_	_
3-43	560-563	the	abstract[22]|abstract[24]|abstract[25]|abstract[26]	new[22]|new[24]|giv[25]|new[26]	_	_
3-44	564-578	property-based	abstract[22]|abstract[24]|abstract[25]|abstract[26]	new[22]|new[24]|giv[25]|new[26]	_	_
3-45	579-587	chemical	abstract[22]|abstract[24]|abstract[25]|abstract[26]	new[22]|new[24]|giv[25]|new[26]	_	_
3-46	588-593	space	abstract[22]|abstract[24]|abstract[25]|abstract[26]	new[22]|new[24]|giv[25]|new[26]	_	_
3-47	594-595	.	_	_	_	_

#Text=The systematic observational of trends of structural chemical modifications that produce corresponding changes in the biological responses for a congeneric series of molecules are fundamental for the multidimensional quantitative structure – activity ( mD-QSAR ) studies .
4-1	596-599	The	abstract[27]	new[27]	_	_
4-2	600-610	systematic	abstract[27]	new[27]	_	_
4-3	611-624	observational	abstract[27]	new[27]	_	_
4-4	625-627	of	abstract[27]	new[27]	_	_
4-5	628-634	trends	abstract[27]|abstract[28]	new[27]|new[28]	_	_
4-6	635-637	of	abstract[27]|abstract[28]	new[27]|new[28]	_	_
4-7	638-648	structural	abstract[27]|abstract[28]|abstract[29]	new[27]|new[28]|new[29]	coref	20-32[214_29]
4-8	649-657	chemical	abstract[27]|abstract[28]|abstract[29]	new[27]|new[28]|new[29]	_	_
4-9	658-671	modifications	abstract[27]|abstract[28]|abstract[29]	new[27]|new[28]|new[29]	_	_
4-10	672-676	that	_	_	_	_
4-11	677-684	produce	_	_	_	_
4-12	685-698	corresponding	_	_	_	_
4-13	699-706	changes	abstract[30]	new[30]	coref	7-21[64_30]
4-14	707-709	in	abstract[30]	new[30]	_	_
4-15	710-713	the	abstract[30]|abstract[31]	new[30]|new[31]	_	_
4-16	714-724	biological	abstract[30]|abstract[31]	new[30]|new[31]	_	_
4-17	725-734	responses	abstract[30]|abstract[31]	new[30]|new[31]	_	_
4-18	735-738	for	abstract[30]|abstract[31]	new[30]|new[31]	_	_
4-19	739-740	a	abstract[30]|abstract[31]|object[32]	new[30]|new[31]|new[32]	_	_
4-20	741-751	congeneric	abstract[30]|abstract[31]|object[32]	new[30]|new[31]|new[32]	_	_
4-21	752-758	series	abstract[30]|abstract[31]|object[32]	new[30]|new[31]|new[32]	_	_
4-22	759-761	of	abstract[30]|abstract[31]|object[32]	new[30]|new[31]|new[32]	_	_
4-23	762-771	molecules	abstract[30]|abstract[31]|object[32]|substance	new[30]|new[31]|new[32]|new	coref	8-12[69_0]
4-24	772-775	are	_	_	_	_
4-25	776-787	fundamental	_	_	_	_
4-26	788-791	for	_	_	_	_
4-27	792-795	the	abstract[34]	new[34]	appos	4-32[0_34]
4-28	796-812	multidimensional	abstract[34]	new[34]	_	_
4-29	813-825	quantitative	abstract[34]	new[34]	_	_
4-30	826-835	structure	abstract[34]	new[34]	_	_
4-31	836-837	–	_	_	_	_
4-32	838-846	activity	abstract	giv	appos	4-34
4-33	847-848	(	_	_	_	_
4-34	849-856	mD-QSAR	abstract	giv	appos	4-36
4-35	857-858	)	_	_	_	_
4-36	859-866	studies	abstract	giv	coref	6-19[53_0]
4-37	867-868	.	_	_	_	_

#Text=Moving from complex biological relationships to simple QSAR models seems to be a ‘ triumph of hope over experience , ’ since modelers sometimes are playing a ‘ glass bead game . ’
5-1	869-875	Moving	_	_	_	_
5-2	876-880	from	_	_	_	_
5-3	881-888	complex	abstract[38]	new[38]	_	_
5-4	889-899	biological	abstract[38]	new[38]	_	_
5-5	900-913	relationships	abstract[38]	new[38]	_	_
5-6	914-916	to	abstract[38]	new[38]	_	_
5-7	917-923	simple	abstract[38]|abstract[40]	new[38]|new[40]	coref	22-11[230_40]
5-8	924-928	QSAR	abstract[38]|organization|abstract[40]	new[38]|new|new[40]	coref	8-9
5-9	929-935	models	abstract[38]|abstract[40]	new[38]|new[40]	_	_
5-10	936-941	seems	_	_	_	_
5-11	942-944	to	_	_	_	_
5-12	945-947	be	_	_	_	_
5-13	948-949	a	event[41]	new[41]	_	_
5-14	950-951	‘	event[41]	new[41]	_	_
5-15	952-959	triumph	event[41]	new[41]	_	_
5-16	960-962	of	event[41]	new[41]	_	_
5-17	963-967	hope	event[41]|abstract	new[41]|new	_	_
5-18	968-972	over	event[41]	new[41]	_	_
5-19	973-983	experience	event[41]|abstract	new[41]|new	_	_
5-20	984-985	,	_	_	_	_
5-21	986-987	’	_	_	_	_
5-22	988-993	since	_	_	_	_
5-23	994-1002	modelers	person	new	_	_
5-24	1003-1012	sometimes	_	_	_	_
5-25	1013-1016	are	_	_	_	_
5-26	1017-1024	playing	_	_	_	_
5-27	1025-1026	a	event[47]	new[47]	_	_
5-28	1027-1028	‘	event[47]	new[47]	_	_
5-29	1029-1034	glass	object|event[47]	new|new[47]	_	_
5-30	1035-1039	bead	object|event[47]	new|new[47]	_	_
5-31	1040-1044	game	event[47]	new[47]	_	_
5-32	1045-1046	.	_	_	_	_
5-33	1047-1048	’	_	_	_	_

#Text=The quantitative mapping of experimental/calculated properties/descriptors into the ADMET-driven molecular potency is frequently a ‘ hit-or-miss affair . ’ Therefore , some structure – activity relationship ( SAR)-mediated guides are urgently needed at the ‘ pre-synthesis ’ stage .
6-1	1049-1052	The	abstract[48]	new[48]	coref	6-13[52_48]
6-2	1053-1065	quantitative	abstract[48]	new[48]	_	_
6-3	1066-1073	mapping	abstract[48]	new[48]	_	_
6-4	1074-1076	of	abstract[48]	new[48]	_	_
6-5	1077-1100	experimental/calculated	abstract[48]|abstract[49]	new[48]|new[49]	_	_
6-6	1101-1123	properties/descriptors	abstract[48]|abstract[49]	new[48]|new[49]	_	_
6-7	1124-1128	into	abstract[48]|abstract[49]	new[48]|new[49]	_	_
6-8	1129-1132	the	abstract[48]|abstract[49]|abstract[51]	new[48]|new[49]|new[51]	coref	16-37[164_51]
6-9	1133-1145	ADMET-driven	abstract[48]|abstract[49]|abstract|abstract[51]	new[48]|new[49]|new|new[51]	_	_
6-10	1146-1155	molecular	abstract[48]|abstract[49]|abstract[51]	new[48]|new[49]|new[51]	_	_
6-11	1156-1163	potency	abstract[48]|abstract[49]|abstract[51]	new[48]|new[49]|new[51]	_	_
6-12	1164-1166	is	_	_	_	_
6-13	1167-1177	frequently	abstract[52]	giv[52]	_	_
6-14	1178-1179	a	abstract[52]	giv[52]	_	_
6-15	1180-1181	‘	abstract[52]	giv[52]	_	_
6-16	1182-1193	hit-or-miss	abstract[52]	giv[52]	_	_
6-17	1194-1200	affair	abstract[52]	giv[52]	_	_
6-18	1201-1202	.	abstract[52]	giv[52]	_	_
6-19	1203-1204	’	abstract[52]|abstract[53]	giv[52]|giv[53]	coref	6-25[0_53]
6-20	1205-1214	Therefore	abstract[52]|abstract[53]	giv[52]|giv[53]	_	_
6-21	1215-1216	,	abstract[52]|abstract[53]	giv[52]|giv[53]	_	_
6-22	1217-1221	some	abstract[52]|abstract[53]	giv[52]|giv[53]	_	_
6-23	1222-1231	structure	abstract[52]|abstract[53]	giv[52]|giv[53]	_	_
6-24	1232-1233	–	abstract[52]	giv[52]	_	_
6-25	1234-1242	activity	abstract[52]|abstract|abstract[55]	giv[52]|giv|new[55]	coref|coref	7-18|7-18
6-26	1243-1255	relationship	abstract[52]|abstract[55]	giv[52]|new[55]	_	_
6-27	1256-1257	(	_	_	_	_
6-28	1258-1271	SAR)-mediated	abstract[56]	new[56]	_	_
6-29	1272-1278	guides	abstract[56]	new[56]	_	_
6-30	1279-1282	are	_	_	_	_
6-31	1283-1291	urgently	_	_	_	_
6-32	1292-1298	needed	_	_	_	_
6-33	1299-1301	at	_	_	_	_
6-34	1302-1305	the	time[58]	new[58]	_	_
6-35	1306-1307	‘	abstract[57]|time[58]	new[57]|new[58]	_	_
6-36	1308-1321	pre-synthesis	abstract[57]|time[58]	new[57]|new[58]	_	_
6-37	1322-1323	’	abstract[57]|time[58]	new[57]|new[58]	_	_
6-38	1324-1329	stage	time[58]	new[58]	_	_
6-39	1330-1331	.	_	_	_	_

#Text=Molecular similarity is unarguably at the core of many SAR-based methods , assuming that small variations in structure lead to small changes in activity .
7-1	1332-1341	Molecular	abstract[59]	new[59]	coref	8-14[70_59]
7-2	1342-1352	similarity	abstract[59]	new[59]	_	_
7-3	1353-1355	is	_	_	_	_
7-4	1356-1366	unarguably	_	_	_	_
7-5	1367-1369	at	_	_	_	_
7-6	1370-1373	the	abstract[60]	new[60]	_	_
7-7	1374-1378	core	abstract[60]	new[60]	_	_
7-8	1379-1381	of	abstract[60]	new[60]	_	_
7-9	1382-1386	many	abstract[60]|abstract[61]	new[60]|new[61]	coref	14-27[0_61]
7-10	1387-1396	SAR-based	abstract[60]|abstract[61]	new[60]|new[61]	_	_
7-11	1397-1404	methods	abstract[60]|abstract[61]	new[60]|new[61]	_	_
7-12	1405-1406	,	_	_	_	_
7-13	1407-1415	assuming	_	_	_	_
7-14	1416-1420	that	_	_	_	_
7-15	1421-1426	small	abstract[62]	new[62]	coref	20-9[208_62]
7-16	1427-1437	variations	abstract[62]	new[62]	_	_
7-17	1438-1440	in	abstract[62]	new[62]	_	_
7-18	1441-1450	structure	abstract[62]|abstract	new[62]|giv	coref	7-24
7-19	1451-1455	lead	abstract[62]	new[62]	_	_
7-20	1456-1458	to	abstract[62]	new[62]	_	_
7-21	1459-1464	small	abstract[62]|abstract[64]	new[62]|giv[64]	coref	16-19[160_64]
7-22	1465-1472	changes	abstract[62]|abstract[64]	new[62]|giv[64]	_	_
7-23	1473-1475	in	abstract[62]|abstract[64]	new[62]|giv[64]	_	_
7-24	1476-1484	activity	abstract[62]|abstract[64]|abstract	new[62]|giv[64]|giv	coref	17-34
7-25	1485-1486	.	_	_	_	_

#Text=In other words , the working tenet of QSAR is that molecules with high similarity share common effects ( similarity principle ) ; however , the validity of the assumption is still questionable — there is no absolute standard ( or metric ) of similarity .
8-1	1487-1489	In	_	_	_	_
8-2	1490-1495	other	abstract[66]	new[66]	coref	17-2[173_66]
8-3	1496-1501	words	abstract[66]	new[66]	_	_
8-4	1502-1503	,	_	_	_	_
8-5	1504-1507	the	abstract[67]	new[67]	_	_
8-6	1508-1515	working	abstract[67]	new[67]	_	_
8-7	1516-1521	tenet	abstract[67]	new[67]	_	_
8-8	1522-1524	of	abstract[67]	new[67]	_	_
8-9	1525-1529	QSAR	abstract[67]|abstract	new[67]|giv	_	_
8-10	1530-1532	is	_	_	_	_
8-11	1533-1537	that	_	_	_	_
8-12	1538-1547	molecules	substance[69]	giv[69]	coref	20-48[218_69]
8-13	1548-1552	with	substance[69]	giv[69]	_	_
8-14	1553-1557	high	substance[69]|abstract[70]	giv[69]|giv[70]	coref	8-20[0_70]
8-15	1558-1568	similarity	substance[69]|abstract[70]	giv[69]|giv[70]	_	_
8-16	1569-1574	share	_	_	_	_
8-17	1575-1581	common	abstract[71]	new[71]	appos	8-20[73_71]
8-18	1582-1589	effects	abstract[71]	new[71]	_	_
8-19	1590-1591	(	_	_	_	_
8-20	1592-1602	similarity	abstract|abstract[73]	giv|giv[73]	coref|coref	8-45|8-45
8-21	1603-1612	principle	abstract[73]	giv[73]	_	_
8-22	1613-1614	)	_	_	_	_
8-23	1615-1616	;	_	_	_	_
8-24	1617-1624	however	_	_	_	_
8-25	1625-1626	,	_	_	_	_
8-26	1627-1630	the	abstract[74]	new[74]	_	_
8-27	1631-1639	validity	abstract[74]	new[74]	_	_
8-28	1640-1642	of	abstract[74]	new[74]	_	_
8-29	1643-1646	the	abstract[74]|abstract[75]	new[74]|new[75]	_	_
8-30	1647-1657	assumption	abstract[74]|abstract[75]	new[74]|new[75]	_	_
8-31	1658-1660	is	_	_	_	_
8-32	1661-1666	still	_	_	_	_
8-33	1667-1679	questionable	_	_	_	_
8-34	1680-1681	—	_	_	_	_
8-35	1682-1687	there	_	_	_	_
8-36	1688-1690	is	_	_	_	_
8-37	1691-1693	no	abstract[76]	new[76]	_	_
8-38	1694-1702	absolute	abstract[76]	new[76]	_	_
8-39	1703-1711	standard	abstract[76]	new[76]	_	_
8-40	1712-1713	(	_	_	_	_
8-41	1714-1716	or	_	_	_	_
8-42	1717-1723	metric	abstract[77]	new[77]	_	_
8-43	1724-1725	)	abstract[77]	new[77]	_	_
8-44	1726-1728	of	abstract[77]	new[77]	_	_
8-45	1729-1739	similarity	abstract[77]|abstract	new[77]|giv	coref	9-4
8-46	1740-1741	.	_	_	_	_

#Text=In fact , similarity is a subjective concept directly related to aspects of human cognition ; this phenomena is sometimes called ‘ psychological proximity ’ .
9-1	1742-1744	In	_	_	_	_
9-2	1745-1749	fact	_	_	_	_
9-3	1750-1751	,	_	_	_	_
9-4	1752-1762	similarity	abstract	giv	coref	9-6[80_0]
9-5	1763-1765	is	_	_	_	_
9-6	1766-1767	a	abstract[80]	giv[80]	coref	10-8[87_80]
9-7	1768-1778	subjective	abstract[80]	giv[80]	_	_
9-8	1779-1786	concept	abstract[80]	giv[80]	_	_
9-9	1787-1795	directly	_	_	_	_
9-10	1796-1803	related	_	_	_	_
9-11	1804-1806	to	_	_	_	_
9-12	1807-1814	aspects	abstract[81]	new[81]	_	_
9-13	1815-1817	of	abstract[81]	new[81]	_	_
9-14	1818-1823	human	abstract[81]|abstract[82]	new[81]|new[82]	_	_
9-15	1824-1833	cognition	abstract[81]|abstract[82]	new[81]|new[82]	_	_
9-16	1834-1835	;	_	_	_	_
9-17	1836-1840	this	abstract[83]	new[83]	_	_
9-18	1841-1850	phenomena	abstract[83]	new[83]	_	_
9-19	1851-1853	is	_	_	_	_
9-20	1854-1863	sometimes	_	_	_	_
9-21	1864-1870	called	_	_	_	_
9-22	1871-1872	‘	abstract[84]	new[84]	_	_
9-23	1873-1886	psychological	abstract[84]	new[84]	_	_
9-24	1887-1896	proximity	abstract[84]	new[84]	_	_
9-25	1897-1898	’	abstract[84]	new[84]	_	_
9-26	1899-1900	.	_	_	_	_

#Text=Maggiora ’s provocative statement that , “ Similarity , like pornography , is difficult to define , but you know it when you see it , ” is probably a better illustration of cognitive aspects of similarity .
10-1	1901-1909	Maggiora	person[85]|abstract[86]	new[85]|new[86]	_	_
10-2	1910-1912	’s	person[85]|abstract[86]	new[85]|new[86]	_	_
10-3	1913-1924	provocative	abstract[86]	new[86]	_	_
10-4	1925-1934	statement	abstract[86]	new[86]	_	_
10-5	1935-1939	that	_	_	_	_
10-6	1940-1941	,	_	_	_	_
10-7	1942-1943	“	_	_	_	_
10-8	1944-1954	Similarity	abstract[87]	giv[87]	coref	10-37[0_87]
10-9	1955-1956	,	abstract[87]	giv[87]	_	_
10-10	1957-1961	like	abstract[87]	giv[87]	_	_
10-11	1962-1973	pornography	abstract[87]|abstract	giv[87]|new	ana	10-21
10-12	1974-1975	,	_	_	_	_
10-13	1976-1978	is	_	_	_	_
10-14	1979-1988	difficult	_	_	_	_
10-15	1989-1991	to	_	_	_	_
10-16	1992-1998	define	_	_	_	_
10-17	1999-2000	,	_	_	_	_
10-18	2001-2004	but	_	_	_	_
10-19	2005-2008	you	person	acc	ana	10-23
10-20	2009-2013	know	_	_	_	_
10-21	2014-2016	it	abstract	giv	ana	10-25
10-22	2017-2021	when	_	_	_	_
10-23	2022-2025	you	person	giv	_	_
10-24	2026-2029	see	_	_	_	_
10-25	2030-2032	it	abstract	giv	_	_
10-26	2033-2034	,	_	_	_	_
10-27	2035-2036	”	_	_	_	_
10-28	2037-2039	is	_	_	_	_
10-29	2040-2048	probably	object[93]	new[93]	_	_
10-30	2049-2050	a	object[93]	new[93]	_	_
10-31	2051-2057	better	object[93]	new[93]	_	_
10-32	2058-2070	illustration	object[93]	new[93]	_	_
10-33	2071-2073	of	object[93]	new[93]	_	_
10-34	2074-2083	cognitive	object[93]|abstract[94]	new[93]|new[94]	_	_
10-35	2084-2091	aspects	object[93]|abstract[94]	new[93]|new[94]	_	_
10-36	2092-2094	of	object[93]|abstract[94]	new[93]|new[94]	_	_
10-37	2095-2105	similarity	object[93]|abstract[94]|abstract	new[93]|new[94]|giv	coref	11-19
10-38	2106-2107	.	_	_	_	_

#Text=Despite the presence of fluid scientific boundaries , e. g. , some similarity metrics exhibit size-dependent behavior — similarity quantification is still a powerful concept that allows us to specify ( with some confidence ) the shared host – quest interactions .
11-1	2108-2115	Despite	_	_	_	_
11-2	2116-2119	the	abstract[96]	new[96]	_	_
11-3	2120-2128	presence	abstract[96]	new[96]	_	_
11-4	2129-2131	of	abstract[96]	new[96]	_	_
11-5	2132-2137	fluid	abstract[96]|abstract[97]	new[96]|new[97]	appos	11-9[98_97]
11-6	2138-2148	scientific	abstract[96]|abstract[97]	new[96]|new[97]	_	_
11-7	2149-2159	boundaries	abstract[96]|abstract[97]	new[96]|new[97]	_	_
11-8	2160-2161	,	_	_	_	_
11-9	2162-2164	e.	abstract[98]	giv[98]	appos	11-12[99_98]
11-10	2165-2167	g.	abstract[98]	giv[98]	_	_
11-11	2168-2169	,	_	_	_	_
11-12	2170-2174	some	abstract[99]	giv[99]	_	_
11-13	2175-2185	similarity	abstract[99]	giv[99]	_	_
11-14	2186-2193	metrics	abstract[99]|abstract	giv[99]|new	coref	24-17[249_0]
11-15	2194-2201	exhibit	abstract[99]	giv[99]	_	_
11-16	2202-2216	size-dependent	abstract[99]|abstract[101]	giv[99]|new[101]	_	_
11-17	2217-2225	behavior	abstract[99]|abstract[101]	giv[99]|new[101]	_	_
11-18	2226-2227	—	_	_	_	_
11-19	2228-2238	similarity	abstract|abstract[103]	giv|new[103]	coref|coref|coref|coref	11-22[104_103]|12-12[112_0]|11-22[104_103]|12-12[112_0]
11-20	2239-2253	quantification	abstract[103]	new[103]	_	_
11-21	2254-2256	is	_	_	_	_
11-22	2257-2262	still	abstract[104]	giv[104]	coref	24-1[242_104]
11-23	2263-2264	a	abstract[104]	giv[104]	_	_
11-24	2265-2273	powerful	abstract[104]	giv[104]	_	_
11-25	2274-2281	concept	abstract[104]	giv[104]	_	_
11-26	2282-2286	that	_	_	_	_
11-27	2287-2293	allows	_	_	_	_
11-28	2294-2296	us	person	acc	ana	18-3
11-29	2297-2299	to	_	_	_	_
11-30	2300-2307	specify	_	_	_	_
11-31	2308-2309	(	_	_	_	_
11-32	2310-2314	with	_	_	_	_
11-33	2315-2319	some	abstract[106]	new[106]	_	_
11-34	2320-2330	confidence	abstract[106]	new[106]	_	_
11-35	2331-2332	)	_	_	_	_
11-36	2333-2336	the	person[107]	new[107]	_	_
11-37	2337-2343	shared	person[107]	new[107]	_	_
11-38	2344-2348	host	person[107]	new[107]	_	_
11-39	2349-2350	–	_	_	_	_
11-40	2351-2356	quest	abstract|abstract[109]	new|new[109]	_	_
11-41	2357-2369	interactions	abstract[109]	new[109]	_	_
11-42	2370-2371	.	_	_	_	_

#Text=In fact , the idea of specifying a numerical measure of the intermolecular similarity based on the degree of the resemblance between two objects , each described by a number of attributes , has been widely applied in chemical information systems .
12-1	2372-2374	In	_	_	_	_
12-2	2375-2379	fact	_	_	_	_
12-3	2380-2381	,	_	_	_	_
12-4	2382-2385	the	abstract[110]	new[110]	coref	16-10[159_110]
12-5	2386-2390	idea	abstract[110]	new[110]	_	_
12-6	2391-2393	of	_	_	_	_
12-7	2394-2404	specifying	_	_	_	_
12-8	2405-2406	a	abstract[111]	new[111]	_	_
12-9	2407-2416	numerical	abstract[111]	new[111]	_	_
12-10	2417-2424	measure	abstract[111]	new[111]	_	_
12-11	2425-2427	of	abstract[111]	new[111]	_	_
12-12	2428-2431	the	abstract[111]|abstract[112]	new[111]|giv[112]	coref	14-51[0_112]
12-13	2432-2446	intermolecular	abstract[111]|abstract[112]	new[111]|giv[112]	_	_
12-14	2447-2457	similarity	abstract[111]|abstract[112]	new[111]|giv[112]	_	_
12-15	2458-2463	based	_	_	_	_
12-16	2464-2466	on	_	_	_	_
12-17	2467-2470	the	abstract[113]	new[113]	_	_
12-18	2471-2477	degree	abstract[113]	new[113]	_	_
12-19	2478-2480	of	abstract[113]	new[113]	_	_
12-20	2481-2484	the	abstract[113]|abstract[114]	new[113]|new[114]	ana	12-26[0_114]
12-21	2485-2496	resemblance	abstract[113]|abstract[114]	new[113]|new[114]	_	_
12-22	2497-2504	between	abstract[113]|abstract[114]	new[113]|new[114]	_	_
12-23	2505-2508	two	abstract[113]|abstract[114]|object[115]	new[113]|new[114]|new[115]	coref	13-37[0_115]
12-24	2509-2516	objects	abstract[113]|abstract[114]|object[115]	new[113]|new[114]|new[115]	_	_
12-25	2517-2518	,	_	_	_	_
12-26	2519-2523	each	abstract	giv	coref	13-33[126_0]
12-27	2524-2533	described	_	_	_	_
12-28	2534-2536	by	_	_	_	_
12-29	2537-2538	a	abstract[117]	new[117]	_	_
12-30	2539-2545	number	abstract[117]	new[117]	_	_
12-31	2546-2548	of	abstract[117]	new[117]	_	_
12-32	2549-2559	attributes	abstract[117]	new[117]	_	_
12-33	2560-2561	,	_	_	_	_
12-34	2562-2565	has	_	_	_	_
12-35	2566-2570	been	_	_	_	_
12-36	2571-2577	widely	_	_	_	_
12-37	2578-2585	applied	_	_	_	_
12-38	2586-2588	in	_	_	_	_
12-39	2589-2597	chemical	abstract[118]	new[118]	_	_
12-40	2598-2609	information	abstract[118]	new[118]	_	_
12-41	2610-2617	systems	abstract[118]	new[118]	_	_
12-42	2618-2619	.	_	_	_	_

#Text=A set of characteristics might be denoted by a bit-string representation , sometimes augmented with the weighting factors , assigning varying importance to the particular descriptors to calculate a quantitative measure of the structural resemblance between objects , for instance Tanimoto coefficient .
13-1	2620-2621	A	abstract[119]	new[119]	coref	14-17[0_119]
13-2	2622-2625	set	abstract[119]	new[119]	_	_
13-3	2626-2628	of	abstract[119]	new[119]	_	_
13-4	2629-2644	characteristics	abstract[119]	new[119]	_	_
13-5	2645-2650	might	_	_	_	_
13-6	2651-2653	be	_	_	_	_
13-7	2654-2661	denoted	_	_	_	_
13-8	2662-2664	by	_	_	_	_
13-9	2665-2666	a	abstract[120]	new[120]	_	_
13-10	2667-2677	bit-string	abstract[120]	new[120]	_	_
13-11	2678-2692	representation	abstract[120]	new[120]	_	_
13-12	2693-2694	,	_	_	_	_
13-13	2695-2704	sometimes	_	_	_	_
13-14	2705-2714	augmented	_	_	_	_
13-15	2715-2719	with	_	_	_	_
13-16	2720-2723	the	abstract[122]	new[122]	_	_
13-17	2724-2733	weighting	abstract|abstract[122]	new|new[122]	_	_
13-18	2734-2741	factors	abstract[122]	new[122]	_	_
13-19	2742-2743	,	_	_	_	_
13-20	2744-2753	assigning	_	_	_	_
13-21	2754-2761	varying	abstract[123]	new[123]	_	_
13-22	2762-2772	importance	abstract[123]	new[123]	_	_
13-23	2773-2775	to	abstract[123]	new[123]	_	_
13-24	2776-2779	the	abstract[123]|abstract[124]	new[123]|giv[124]	_	_
13-25	2780-2790	particular	abstract[123]|abstract[124]	new[123]|giv[124]	_	_
13-26	2791-2802	descriptors	abstract[123]|abstract[124]	new[123]|giv[124]	_	_
13-27	2803-2805	to	_	_	_	_
13-28	2806-2815	calculate	_	_	_	_
13-29	2816-2817	a	abstract[125]	new[125]	_	_
13-30	2818-2830	quantitative	abstract[125]	new[125]	_	_
13-31	2831-2838	measure	abstract[125]	new[125]	_	_
13-32	2839-2841	of	abstract[125]	new[125]	_	_
13-33	2842-2845	the	abstract[125]|abstract[126]	new[125]|giv[126]	_	_
13-34	2846-2856	structural	abstract[125]|abstract[126]	new[125]|giv[126]	_	_
13-35	2857-2868	resemblance	abstract[125]|abstract[126]	new[125]|giv[126]	_	_
13-36	2869-2876	between	abstract[125]|abstract[126]	new[125]|giv[126]	_	_
13-37	2877-2884	objects	abstract[125]|abstract[126]|object	new[125]|giv[126]|giv	_	_
13-38	2885-2886	,	_	_	_	_
13-39	2887-2890	for	_	_	_	_
13-40	2891-2899	instance	_	_	_	_
13-41	2900-2908	Tanimoto	person|abstract[129]	new|new[129]	_	_
13-42	2909-2920	coefficient	abstract[129]	new[129]	_	_
13-43	2921-2922	.	_	_	_	_

#Text=Obviously , a crucial question that confronts drug ‘ hunters ’ is , which properties or features should be employed in the receptor-dependent ( RD ) methods that rely on the principle of complementarity or in the receptor-independent ( RI ) ones that are mainly based on the principle of similarity ?
14-1	2923-2932	Obviously	abstract[130]	new[130]	coref	23-11[235_130]
14-2	2933-2934	,	abstract[130]	new[130]	_	_
14-3	2935-2936	a	abstract[130]	new[130]	_	_
14-4	2937-2944	crucial	abstract[130]	new[130]	_	_
14-5	2945-2953	question	abstract[130]	new[130]	_	_
14-6	2954-2958	that	_	_	_	_
14-7	2959-2968	confronts	_	_	_	_
14-8	2969-2973	drug	substance	giv	coref	15-46
14-9	2974-2975	‘	person[132]|abstract[133]	new[132]|giv[133]	coref|coref	17-10[175_133]|17-10[175_133]
14-10	2976-2983	hunters	person[132]|abstract[133]	new[132]|giv[133]	_	_
14-11	2984-2985	’	person[132]|abstract[133]	new[132]|giv[133]	_	_
14-12	2986-2988	is	abstract[133]	giv[133]	_	_
14-13	2989-2990	,	abstract[133]	giv[133]	_	_
14-14	2991-2996	which	abstract[133]	giv[133]	_	_
14-15	2997-3007	properties	abstract[133]	giv[133]	_	_
14-16	3008-3010	or	abstract[133]	giv[133]	_	_
14-17	3011-3019	features	abstract[133]|abstract	giv[133]|giv	_	_
14-18	3020-3026	should	_	_	_	_
14-19	3027-3029	be	_	_	_	_
14-20	3030-3038	employed	_	_	_	_
14-21	3039-3041	in	_	_	_	_
14-22	3042-3045	the	abstract[135]	new[135]	_	_
14-23	3046-3064	receptor-dependent	abstract[135]	new[135]	_	_
14-24	3065-3066	(	_	_	_	_
14-25	3067-3069	RD	person	new	_	_
14-26	3070-3071	)	_	_	_	_
14-27	3072-3079	methods	abstract	giv	_	_
14-28	3080-3084	that	_	_	_	_
14-29	3085-3089	rely	_	_	_	_
14-30	3090-3092	on	_	_	_	_
14-31	3093-3096	the	abstract[138]	new[138]	_	_
14-32	3097-3106	principle	abstract[138]	new[138]	_	_
14-33	3107-3109	of	abstract[138]	new[138]	_	_
14-34	3110-3125	complementarity	abstract[138]|abstract	new[138]|new	_	_
14-35	3126-3128	or	_	_	_	_
14-36	3129-3131	in	_	_	_	_
14-37	3132-3135	the	abstract[140]	new[140]	_	_
14-38	3136-3156	receptor-independent	abstract[140]	new[140]	_	_
14-39	3157-3158	(	_	_	_	_
14-40	3159-3161	RI	organization	new	_	_
14-41	3162-3163	)	_	_	_	_
14-42	3164-3168	ones	object	new	_	_
14-43	3169-3173	that	_	_	_	_
14-44	3174-3177	are	_	_	_	_
14-45	3178-3184	mainly	_	_	_	_
14-46	3185-3190	based	_	_	_	_
14-47	3191-3193	on	_	_	_	_
14-48	3194-3197	the	abstract[143]	new[143]	_	_
14-49	3198-3207	principle	abstract[143]	new[143]	_	_
14-50	3208-3210	of	abstract[143]	new[143]	_	_
14-51	3211-3221	similarity	abstract[143]|abstract	new[143]|giv	coref	24-17
14-52	3222-3223	?	_	_	_	_

#Text=Hence , many attempts have been undertaken in order to implement some rough guidelines , sometimes called ‘ rules of thumb ’ for both the ligand and structure-based in silico protocols ; however , even meeting the rules does not guarantee the final success of drug discovery projects .
15-1	3224-3229	Hence	_	_	_	_
15-2	3230-3231	,	_	_	_	_
15-3	3232-3236	many	event[145]	new[145]	_	_
15-4	3237-3245	attempts	event[145]	new[145]	_	_
15-5	3246-3250	have	_	_	_	_
15-6	3251-3255	been	_	_	_	_
15-7	3256-3266	undertaken	_	_	_	_
15-8	3267-3269	in	_	_	_	_
15-9	3270-3275	order	_	_	_	_
15-10	3276-3278	to	_	_	_	_
15-11	3279-3288	implement	_	_	_	_
15-12	3289-3293	some	abstract[146]	new[146]	_	_
15-13	3294-3299	rough	abstract[146]	new[146]	_	_
15-14	3300-3310	guidelines	abstract[146]	new[146]	_	_
15-15	3311-3312	,	_	_	_	_
15-16	3313-3322	sometimes	_	_	_	_
15-17	3323-3329	called	_	_	_	_
15-18	3330-3331	‘	abstract[147]	new[147]	coref	15-37[152_147]
15-19	3332-3337	rules	abstract[147]	new[147]	_	_
15-20	3338-3340	of	abstract[147]	new[147]	_	_
15-21	3341-3346	thumb	abstract[147]|abstract[148]|abstract[149]	new[147]|new[148]|new[149]	_	_
15-22	3347-3348	’	abstract[147]|abstract[148]|abstract[149]	new[147]|new[148]|new[149]	_	_
15-23	3349-3352	for	abstract[147]|abstract[149]	new[147]|new[149]	_	_
15-24	3353-3357	both	abstract[147]|abstract[149]	new[147]|new[149]	_	_
15-25	3358-3361	the	abstract[147]|abstract[149]	new[147]|new[149]	_	_
15-26	3362-3368	ligand	abstract[147]|abstract[149]	new[147]|new[149]	_	_
15-27	3369-3372	and	abstract[147]	new[147]	_	_
15-28	3373-3388	structure-based	abstract[147]	new[147]	_	_
15-29	3389-3391	in	_	_	_	_
15-30	3392-3398	silico	abstract|abstract[151]	giv|new[151]	_	_
15-31	3399-3408	protocols	abstract[151]	new[151]	_	_
15-32	3409-3410	;	_	_	_	_
15-33	3411-3418	however	_	_	_	_
15-34	3419-3420	,	_	_	_	_
15-35	3421-3425	even	_	_	_	_
15-36	3426-3433	meeting	_	_	_	_
15-37	3434-3437	the	abstract[152]	giv[152]	_	_
15-38	3438-3443	rules	abstract[152]	giv[152]	_	_
15-39	3444-3448	does	_	_	_	_
15-40	3449-3452	not	_	_	_	_
15-41	3453-3462	guarantee	_	_	_	_
15-42	3463-3466	the	event[153]	new[153]	_	_
15-43	3467-3472	final	event[153]	new[153]	_	_
15-44	3473-3480	success	event[153]	new[153]	_	_
15-45	3481-3483	of	event[153]	new[153]	_	_
15-46	3484-3488	drug	event[153]|substance|abstract[156]	new[153]|giv|giv[156]	coref|coref	17-14|17-14
15-47	3489-3498	discovery	event[153]|abstract|abstract[156]	new[153]|giv|giv[156]	_	_
15-48	3499-3507	projects	event[153]|abstract[156]	new[153]|giv[156]	_	_
15-49	3508-3509	.	_	_	_	_

#Text=A confusing aspect of many SAR analyses is that the ‘ fragile event ’ can occur , when even small structural changes ( colloquially termed ‘ magic methyl ’ ) can result in a boost of potency for the target , or in a more detrimental manner , can completely destroy biological response — a phenomenon known as activity ‘ hotspot ’ or activity ‘ cliff ’ in structure-activity landscape .
16-1	3510-3511	A	abstract[157]	new[157]	_	_
16-2	3512-3521	confusing	abstract[157]	new[157]	_	_
16-3	3522-3528	aspect	abstract[157]	new[157]	_	_
16-4	3529-3531	of	abstract[157]	new[157]	_	_
16-5	3532-3536	many	abstract[157]|abstract[158]	new[157]|new[158]	_	_
16-6	3537-3540	SAR	abstract[157]|abstract[158]	new[157]|new[158]	_	_
16-7	3541-3549	analyses	abstract[157]|abstract[158]	new[157]|new[158]	_	_
16-8	3550-3552	is	_	_	_	_
16-9	3553-3557	that	_	_	_	_
16-10	3558-3561	the	abstract[159]	giv[159]	_	_
16-11	3562-3563	‘	abstract[159]	giv[159]	_	_
16-12	3564-3571	fragile	abstract[159]	giv[159]	_	_
16-13	3572-3577	event	abstract[159]	giv[159]	_	_
16-14	3578-3579	’	abstract[159]	giv[159]	_	_
16-15	3580-3583	can	_	_	_	_
16-16	3584-3589	occur	_	_	_	_
16-17	3590-3591	,	_	_	_	_
16-18	3592-3596	when	_	_	_	_
16-19	3597-3601	even	abstract[160]	giv[160]	coref	20-15[209_160]
16-20	3602-3607	small	abstract[160]	giv[160]	_	_
16-21	3608-3618	structural	abstract[160]	giv[160]	_	_
16-22	3619-3626	changes	abstract[160]	giv[160]	_	_
16-23	3627-3628	(	_	_	_	_
16-24	3629-3641	colloquially	_	_	_	_
16-25	3642-3648	termed	_	_	_	_
16-26	3649-3650	‘	_	_	_	_
16-27	3651-3656	magic	abstract|abstract[162]	new|new[162]	_	_
16-28	3657-3663	methyl	abstract[162]	new[162]	_	_
16-29	3664-3665	’	_	_	_	_
16-30	3666-3667	)	_	_	_	_
16-31	3668-3671	can	_	_	_	_
16-32	3672-3678	result	_	_	_	_
16-33	3679-3681	in	_	_	_	_
16-34	3682-3683	a	event[163]	new[163]	_	_
16-35	3684-3689	boost	event[163]	new[163]	_	_
16-36	3690-3692	of	event[163]	new[163]	_	_
16-37	3693-3700	potency	event[163]|abstract[164]	new[163]|giv[164]	coref	17-13[177_164]
16-38	3701-3704	for	event[163]|abstract[164]	new[163]|giv[164]	_	_
16-39	3705-3708	the	event[163]|abstract[164]|abstract[165]	new[163]|giv[164]|new[165]	_	_
16-40	3709-3715	target	event[163]|abstract[164]|abstract[165]	new[163]|giv[164]|new[165]	_	_
16-41	3716-3717	,	_	_	_	_
16-42	3718-3720	or	_	_	_	_
16-43	3721-3723	in	_	_	_	_
16-44	3724-3725	a	abstract[166]	new[166]	_	_
16-45	3726-3730	more	abstract[166]	new[166]	_	_
16-46	3731-3742	detrimental	abstract[166]	new[166]	_	_
16-47	3743-3749	manner	abstract[166]	new[166]	_	_
16-48	3750-3751	,	_	_	_	_
16-49	3752-3755	can	_	_	_	_
16-50	3756-3766	completely	_	_	_	_
16-51	3767-3774	destroy	_	_	_	_
16-52	3775-3785	biological	abstract[167]	new[167]	coref	17-43[0_167]
16-53	3786-3794	response	abstract[167]	new[167]	_	_
16-54	3795-3796	—	_	_	_	_
16-55	3797-3798	a	abstract[168]	new[168]	_	_
16-56	3799-3809	phenomenon	abstract[168]	new[168]	_	_
16-57	3810-3815	known	_	_	_	_
16-58	3816-3818	as	_	_	_	_
16-59	3819-3827	activity	_	_	_	_
16-60	3828-3829	‘	abstract[169]	new[169]	_	_
16-61	3830-3837	hotspot	abstract[169]	new[169]	_	_
16-62	3838-3839	’	abstract[169]	new[169]	_	_
16-63	3840-3842	or	_	_	_	_
16-64	3843-3851	activity	_	_	_	_
16-65	3852-3853	‘	object[170]|abstract[172]	new[170]|new[172]	coref|coref	21-30[226_172]|21-30[226_172]
16-66	3854-3859	cliff	object[170]|abstract[172]	new[170]|new[172]	_	_
16-67	3860-3861	’	object[170]|abstract[172]	new[170]|new[172]	_	_
16-68	3862-3864	in	abstract[172]	new[172]	_	_
16-69	3865-3883	structure-activity	abstract|abstract[172]	new|new[172]	_	_
16-70	3884-3893	landscape	abstract[172]	new[172]	_	_
16-71	3894-3895	.	_	_	_	_

#Text=In other words , finding the optimal balance between ADMET-related properties and desired drug potency ( ‘ sweet spot ’ ) can be rationalized graphically by extension of the 2D similarity-based projection with activity data in the form of a ‘ biological response surface ’ or SAR landscapes .
17-1	3896-3898	In	_	_	_	_
17-2	3899-3904	other	abstract[173]	giv[173]	_	_
17-3	3905-3910	words	abstract[173]	giv[173]	_	_
17-4	3911-3912	,	_	_	_	_
17-5	3913-3920	finding	_	_	_	_
17-6	3921-3924	the	abstract[174]	new[174]	_	_
17-7	3925-3932	optimal	abstract[174]	new[174]	_	_
17-8	3933-3940	balance	abstract[174]	new[174]	_	_
17-9	3941-3948	between	abstract[174]	new[174]	_	_
17-10	3949-3962	ADMET-related	abstract[174]|abstract[175]	new[174]|giv[175]	_	_
17-11	3963-3973	properties	abstract[174]|abstract[175]	new[174]|giv[175]	_	_
17-12	3974-3977	and	abstract[174]|abstract[175]	new[174]|giv[175]	_	_
17-13	3978-3985	desired	abstract[174]|abstract[175]|abstract[177]	new[174]|giv[175]|giv[177]	_	_
17-14	3986-3990	drug	abstract[174]|abstract[175]|substance|abstract[177]	new[174]|giv[175]|giv|giv[177]	_	_
17-15	3991-3998	potency	abstract[174]|abstract[175]|abstract[177]	new[174]|giv[175]|giv[177]	_	_
17-16	3999-4000	(	_	_	_	_
17-17	4001-4002	‘	_	_	_	_
17-18	4003-4008	sweet	place[178]	new[178]	_	_
17-19	4009-4013	spot	place[178]	new[178]	_	_
17-20	4014-4015	’	_	_	_	_
17-21	4016-4017	)	_	_	_	_
17-22	4018-4021	can	_	_	_	_
17-23	4022-4024	be	_	_	_	_
17-24	4025-4037	rationalized	_	_	_	_
17-25	4038-4049	graphically	_	_	_	_
17-26	4050-4052	by	_	_	_	_
17-27	4053-4062	extension	abstract[179]	new[179]	_	_
17-28	4063-4065	of	abstract[179]	new[179]	_	_
17-29	4066-4069	the	abstract[179]|object[180]	new[179]|new[180]	_	_
17-30	4070-4072	2D	abstract[179]|object[180]	new[179]|new[180]	_	_
17-31	4073-4089	similarity-based	abstract[179]|object[180]	new[179]|new[180]	_	_
17-32	4090-4100	projection	abstract[179]|object[180]	new[179]|new[180]	_	_
17-33	4101-4105	with	abstract[179]|object[180]	new[179]|new[180]	_	_
17-34	4106-4114	activity	abstract[179]|object[180]|abstract|abstract[182]	new[179]|new[180]|giv|new[182]	coref|coref	18-6[189_0]|18-6[189_0]
17-35	4115-4119	data	abstract[179]|object[180]|abstract[182]	new[179]|new[180]|new[182]	_	_
17-36	4120-4122	in	abstract[179]	new[179]	_	_
17-37	4123-4126	the	abstract[179]|abstract[183]	new[179]|new[183]	_	_
17-38	4127-4131	form	abstract[179]|abstract[183]	new[179]|new[183]	_	_
17-39	4132-4134	of	abstract[179]|abstract[183]	new[179]|new[183]	_	_
17-40	4135-4136	a	abstract[179]|abstract[183]|abstract[187]	new[179]|new[183]|new[187]	coref	18-9[192_187]
17-41	4137-4138	‘	abstract[179]|abstract[183]|place[185]|abstract[187]	new[179]|new[183]|new[185]|new[187]	_	_
17-42	4139-4149	biological	abstract[179]|abstract[183]|place[185]|abstract[187]	new[179]|new[183]|new[185]|new[187]	_	_
17-43	4150-4158	response	abstract[179]|abstract[183]|abstract|place[185]|abstract[187]	new[179]|new[183]|giv|new[185]|new[187]	coref	21-23
17-44	4159-4166	surface	abstract[179]|abstract[183]|place[185]|abstract[187]	new[179]|new[183]|new[185]|new[187]	_	_
17-45	4167-4168	’	abstract[179]|abstract[183]|place[185]|abstract[187]	new[179]|new[183]|new[185]|new[187]	_	_
17-46	4169-4171	or	abstract[179]|abstract[183]|abstract[187]	new[179]|new[183]|new[187]	_	_
17-47	4172-4175	SAR	abstract[179]|abstract[183]|place|abstract[187]	new[179]|new[183]|new|new[187]	coref	20-23
17-48	4176-4186	landscapes	abstract[179]|abstract[183]|abstract[187]	new[179]|new[183]|new[187]	_	_
17-49	4187-4188	.	_	_	_	_

#Text=Intuitively , we feel that the structure – activity landscapes are heterogeneous in nature with unevenly distributed regions that are reminiscent of Tolkien ’s Misty Mountains with gently slopes , steep cliffs and stony bridges .
18-1	4189-4200	Intuitively	_	_	_	_
18-2	4201-4202	,	_	_	_	_
18-3	4203-4205	we	person	giv	_	_
18-4	4206-4210	feel	_	_	_	_
18-5	4211-4215	that	_	_	_	_
18-6	4216-4219	the	abstract[189]|abstract[190]	giv[189]|new[190]	coref|coref|coref|coref	18-9[0_189]|24-23[251_190]|18-9[0_189]|24-23[251_190]
18-7	4220-4229	structure	abstract[189]|abstract[190]	giv[189]|new[190]	_	_
18-8	4230-4231	–	abstract[190]	new[190]	_	_
18-9	4232-4240	activity	abstract[190]|abstract|abstract[192]	new[190]|giv|giv[192]	coref|coref|coref|coref	20-18|20-20[212_192]|20-18|20-20[212_192]
18-10	4241-4251	landscapes	abstract[190]|abstract[192]	new[190]|giv[192]	_	_
18-11	4252-4255	are	_	_	_	_
18-12	4256-4269	heterogeneous	_	_	_	_
18-13	4270-4272	in	_	_	_	_
18-14	4273-4279	nature	abstract[193]	new[193]	_	_
18-15	4280-4284	with	abstract[193]	new[193]	_	_
18-16	4285-4293	unevenly	abstract[193]|place[194]	new[193]|new[194]	coref	19-14[204_194]
18-17	4294-4305	distributed	abstract[193]|place[194]	new[193]|new[194]	_	_
18-18	4306-4313	regions	abstract[193]|place[194]	new[193]|new[194]	_	_
18-19	4314-4318	that	_	_	_	_
18-20	4319-4322	are	_	_	_	_
18-21	4323-4334	reminiscent	_	_	_	_
18-22	4335-4337	of	_	_	_	_
18-23	4338-4345	Tolkien	person[195]|object[197]	new[195]|new[197]	_	_
18-24	4346-4348	’s	person[195]|object[197]	new[195]|new[197]	_	_
18-25	4349-4354	Misty	person|object[197]	new|new[197]	_	_
18-26	4355-4364	Mountains	object[197]	new[197]	_	_
18-27	4365-4369	with	object[197]	new[197]	_	_
18-28	4370-4376	gently	object[197]|abstract[198]	new[197]|new[198]	_	_
18-29	4377-4383	slopes	object[197]|abstract[198]	new[197]|new[198]	_	_
18-30	4384-4385	,	object[197]	new[197]	_	_
18-31	4386-4391	steep	object[197]|object[199]	new[197]|new[199]	coref	21-27[224_199]
18-32	4392-4398	cliffs	object[197]|object[199]	new[197]|new[199]	_	_
18-33	4399-4402	and	object[197]	new[197]	_	_
18-34	4403-4408	stony	object[197]|object[200]	new[197]|new[200]	coref	22-3[227_200]
18-35	4409-4416	bridges	object[197]|object[200]	new[197]|new[200]	_	_
18-36	4417-4418	.	_	_	_	_

#Text=Geographically , a successful voyage ( or exploration ) requires a map indicating smooth and flat regions that are easy to navigate or jagged parts that are tough to traverse .
19-1	4419-4433	Geographically	_	_	_	_
19-2	4434-4435	,	_	_	_	_
19-3	4436-4437	a	event[201]	new[201]	_	_
19-4	4438-4448	successful	event[201]	new[201]	_	_
19-5	4449-4455	voyage	event[201]	new[201]	_	_
19-6	4456-4457	(	_	_	_	_
19-7	4458-4460	or	_	_	_	_
19-8	4461-4472	exploration	event	new	_	_
19-9	4473-4474	)	_	_	_	_
19-10	4475-4483	requires	_	_	_	_
19-11	4484-4485	a	object[203]	new[203]	_	_
19-12	4486-4489	map	object[203]	new[203]	_	_
19-13	4490-4500	indicating	_	_	_	_
19-14	4501-4507	smooth	place[204]	giv[204]	coref	21-11[220_204]
19-15	4508-4511	and	place[204]	giv[204]	_	_
19-16	4512-4516	flat	place[204]	giv[204]	_	_
19-17	4517-4524	regions	place[204]	giv[204]	_	_
19-18	4525-4529	that	_	_	_	_
19-19	4530-4533	are	_	_	_	_
19-20	4534-4538	easy	_	_	_	_
19-21	4539-4541	to	_	_	_	_
19-22	4542-4550	navigate	_	_	_	_
19-23	4551-4553	or	_	_	_	_
19-24	4554-4560	jagged	abstract[205]	new[205]	_	_
19-25	4561-4566	parts	abstract[205]	new[205]	_	_
19-26	4567-4571	that	_	_	_	_
19-27	4572-4575	are	_	_	_	_
19-28	4576-4581	tough	_	_	_	_
19-29	4582-4584	to	_	_	_	_
19-30	4585-4593	traverse	_	_	_	_
19-31	4594-4595	.	_	_	_	_

#Text=Chemically , gently sloped hills pinpoint areas where gradual structural variations are accompanied by moderate changes in activity , whereas in flat SAR landscapes , the biological data varies little over the wide modifications in the compound structure — further substitutions are not likely to result in more potent molecules .
20-1	4596-4606	Chemically	_	_	_	_
20-2	4607-4608	,	_	_	_	_
20-3	4609-4615	gently	object[206]	new[206]	_	_
20-4	4616-4622	sloped	object[206]	new[206]	_	_
20-5	4623-4628	hills	object[206]	new[206]	_	_
20-6	4629-4637	pinpoint	_	_	_	_
20-7	4638-4643	areas	place	new	_	_
20-8	4644-4649	where	_	_	_	_
20-9	4650-4657	gradual	abstract[208]	giv[208]	coref	21-22[223_208]
20-10	4658-4668	structural	abstract[208]	giv[208]	_	_
20-11	4669-4679	variations	abstract[208]	giv[208]	_	_
20-12	4680-4683	are	_	_	_	_
20-13	4684-4695	accompanied	_	_	_	_
20-14	4696-4698	by	_	_	_	_
20-15	4699-4707	moderate	abstract[209]	giv[209]	_	_
20-16	4708-4715	changes	abstract[209]	giv[209]	_	_
20-17	4716-4718	in	abstract[209]	giv[209]	_	_
20-18	4719-4727	activity	abstract[209]|abstract	giv[209]|giv	coref	20-36[216_0]
20-19	4728-4729	,	_	_	_	_
20-20	4730-4737	whereas	abstract[212]	giv[212]	_	_
20-21	4738-4740	in	abstract[212]	giv[212]	_	_
20-22	4741-4745	flat	abstract[212]	giv[212]	_	_
20-23	4746-4749	SAR	substance|abstract[212]	giv|giv[212]	coref	22-13
20-24	4750-4760	landscapes	abstract[212]	giv[212]	_	_
20-25	4761-4762	,	_	_	_	_
20-26	4763-4766	the	abstract[213]	new[213]	_	_
20-27	4767-4777	biological	abstract[213]	new[213]	_	_
20-28	4778-4782	data	abstract[213]	new[213]	_	_
20-29	4783-4789	varies	_	_	_	_
20-30	4790-4796	little	_	_	_	_
20-31	4797-4801	over	_	_	_	_
20-32	4802-4805	the	abstract[214]	giv[214]	coref	21-5[219_214]
20-33	4806-4810	wide	abstract[214]	giv[214]	_	_
20-34	4811-4824	modifications	abstract[214]	giv[214]	_	_
20-35	4825-4827	in	abstract[214]	giv[214]	_	_
20-36	4828-4831	the	abstract[214]|abstract[216]	giv[214]|giv[216]	coref	21-31[0_216]
20-37	4832-4840	compound	abstract[214]|place|abstract[216]	giv[214]|new|giv[216]	_	_
20-38	4841-4850	structure	abstract[214]|abstract[216]	giv[214]|giv[216]	_	_
20-39	4851-4852	—	_	_	_	_
20-40	4853-4860	further	event[217]	new[217]	_	_
20-41	4861-4874	substitutions	event[217]	new[217]	_	_
20-42	4875-4878	are	_	_	_	_
20-43	4879-4882	not	_	_	_	_
20-44	4883-4889	likely	_	_	_	_
20-45	4890-4892	to	_	_	_	_
20-46	4893-4899	result	_	_	_	_
20-47	4900-4902	in	_	_	_	_
20-48	4903-4907	more	substance[218]	giv[218]	coref	22-9[0_218]
20-49	4908-4914	potent	substance[218]	giv[218]	_	_
20-50	4915-4924	molecules	substance[218]	giv[218]	_	_
20-51	4925-4926	.	_	_	_	_

#Text=In fact , disallowed structural modifications can be highlighted in the sharply non-uniform regions where chemically related compounds are characterized by huge response variations , forming steep cliffs in the activity landscape .
21-1	4927-4929	In	_	_	_	_
21-2	4930-4934	fact	_	_	_	_
21-3	4935-4936	,	_	_	_	_
21-4	4937-4947	disallowed	_	_	_	_
21-5	4948-4958	structural	abstract[219]	giv[219]	_	_
21-6	4959-4972	modifications	abstract[219]	giv[219]	_	_
21-7	4973-4976	can	_	_	_	_
21-8	4977-4979	be	_	_	_	_
21-9	4980-4991	highlighted	_	_	_	_
21-10	4992-4994	in	_	_	_	_
21-11	4995-4998	the	place[220]	giv[220]	_	_
21-12	4999-5006	sharply	place[220]	giv[220]	_	_
21-13	5007-5018	non-uniform	place[220]	giv[220]	_	_
21-14	5019-5026	regions	place[220]	giv[220]	_	_
21-15	5027-5032	where	_	_	_	_
21-16	5033-5043	chemically	substance[221]	new[221]	_	_
21-17	5044-5051	related	substance[221]	new[221]	_	_
21-18	5052-5061	compounds	substance[221]	new[221]	_	_
21-19	5062-5065	are	_	_	_	_
21-20	5066-5079	characterized	_	_	_	_
21-21	5080-5082	by	_	_	_	_
21-22	5083-5087	huge	abstract[223]	giv[223]	_	_
21-23	5088-5096	response	abstract|abstract[223]	giv|giv[223]	_	_
21-24	5097-5107	variations	abstract[223]	giv[223]	_	_
21-25	5108-5109	,	_	_	_	_
21-26	5110-5117	forming	_	_	_	_
21-27	5118-5123	steep	object[224]	giv[224]	coref	24-5[244_224]
21-28	5124-5130	cliffs	object[224]	giv[224]	_	_
21-29	5131-5133	in	object[224]	giv[224]	_	_
21-30	5134-5137	the	object[224]|abstract[226]	giv[224]|giv[226]	coref	24-27[0_226]
21-31	5138-5146	activity	object[224]|abstract|abstract[226]	giv[224]|giv|giv[226]	coref	23-5
21-32	5147-5156	landscape	object[224]|abstract[226]	giv[224]|giv[226]	_	_
21-33	5157-5158	.	_	_	_	_

#Text=Moreover , chemical bridges can be observed with molecules connecting different local SAR models .
22-1	5159-5167	Moreover	_	_	_	_
22-2	5168-5169	,	_	_	_	_
22-3	5170-5178	chemical	object[227]	giv[227]	_	_
22-4	5179-5186	bridges	object[227]	giv[227]	_	_
22-5	5187-5190	can	_	_	_	_
22-6	5191-5193	be	_	_	_	_
22-7	5194-5202	observed	_	_	_	_
22-8	5203-5207	with	_	_	_	_
22-9	5208-5217	molecules	substance	giv	_	_
22-10	5218-5228	connecting	_	_	_	_
22-11	5229-5238	different	abstract[230]	giv[230]	_	_
22-12	5239-5244	local	abstract[230]	giv[230]	_	_
22-13	5245-5248	SAR	place|abstract[230]	giv|giv[230]	coref	24-37
22-14	5249-5255	models	abstract[230]	giv[230]	_	_
22-15	5256-5257	.	_	_	_	_

#Text=The detection of the activity hotspots provides reasonable hints to the key question of medicinal chemistry regarding the impact of molecule rearrangement on the activity profile .
23-1	5258-5261	The	abstract[231]	new[231]	_	_
23-2	5262-5271	detection	abstract[231]	new[231]	_	_
23-3	5272-5274	of	abstract[231]	new[231]	_	_
23-4	5275-5278	the	abstract[231]|abstract[233]	new[231]|new[233]	_	_
23-5	5279-5287	activity	abstract[231]|abstract|abstract[233]	new[231]|giv|new[233]	coref	23-25
23-6	5288-5296	hotspots	abstract[231]|abstract[233]	new[231]|new[233]	_	_
23-7	5297-5305	provides	_	_	_	_
23-8	5306-5316	reasonable	abstract[234]	new[234]	_	_
23-9	5317-5322	hints	abstract[234]	new[234]	_	_
23-10	5323-5325	to	abstract[234]	new[234]	_	_
23-11	5326-5329	the	abstract[234]|abstract[235]	new[234]|giv[235]	_	_
23-12	5330-5333	key	abstract[234]|abstract[235]	new[234]|giv[235]	_	_
23-13	5334-5342	question	abstract[234]|abstract[235]	new[234]|giv[235]	_	_
23-14	5343-5345	of	abstract[234]|abstract[235]	new[234]|giv[235]	_	_
23-15	5346-5355	medicinal	abstract[234]|abstract[235]|abstract[236]	new[234]|giv[235]|new[236]	_	_
23-16	5356-5365	chemistry	abstract[234]|abstract[235]|abstract[236]	new[234]|giv[235]|new[236]	_	_
23-17	5366-5375	regarding	_	_	_	_
23-18	5376-5379	the	abstract[237]	new[237]	_	_
23-19	5380-5386	impact	abstract[237]	new[237]	_	_
23-20	5387-5389	of	abstract[237]	new[237]	_	_
23-21	5390-5398	molecule	abstract[237]|abstract|abstract[239]	new[237]|new|new[239]	_	_
23-22	5399-5412	rearrangement	abstract[237]|abstract[239]	new[237]|new[239]	_	_
23-23	5413-5415	on	abstract[237]|abstract[239]	new[237]|new[239]	_	_
23-24	5416-5419	the	abstract[237]|abstract[239]|abstract[241]	new[237]|new[239]|new[241]	_	_
23-25	5420-5428	activity	abstract[237]|abstract[239]|abstract|abstract[241]	new[237]|new[239]|giv|new[241]	coref	24-5
23-26	5429-5436	profile	abstract[237]|abstract[239]|abstract[241]	new[237]|new[239]|new[241]	_	_
23-27	5437-5438	.	_	_	_	_

#Text=The numerical quantification of activity cliffs is frequently performed using a variety of fingerprint representations or similarity metrics ; for instance , the structure – activity landscape index ( SALI ) has been proposed to evaluate SAR smoothness .
24-1	5439-5442	The	abstract[242]	giv[242]	_	_
24-2	5443-5452	numerical	abstract[242]	giv[242]	_	_
24-3	5453-5467	quantification	abstract[242]	giv[242]	_	_
24-4	5468-5470	of	abstract[242]	giv[242]	_	_
24-5	5471-5479	activity	abstract[242]|abstract|object[244]	giv[242]|giv|giv[244]	coref|coref	24-23[250_0]|24-23[250_0]
24-6	5480-5486	cliffs	abstract[242]|object[244]	giv[242]|giv[244]	_	_
24-7	5487-5489	is	_	_	_	_
24-8	5490-5500	frequently	_	_	_	_
24-9	5501-5510	performed	_	_	_	_
24-10	5511-5516	using	_	_	_	_
24-11	5517-5518	a	abstract[245]	new[245]	_	_
24-12	5519-5526	variety	abstract[245]	new[245]	_	_
24-13	5527-5529	of	abstract[245]	new[245]	_	_
24-14	5530-5541	fingerprint	abstract[245]|object|abstract[247]	new[245]|new|new[247]	_	_
24-15	5542-5557	representations	abstract[245]|abstract[247]	new[245]|new[247]	_	_
24-16	5558-5560	or	abstract[245]	new[245]	_	_
24-17	5561-5571	similarity	abstract[245]|abstract|abstract[249]	new[245]|giv|giv[249]	_	_
24-18	5572-5579	metrics	abstract[245]|abstract[249]	new[245]|giv[249]	_	_
24-19	5580-5581	;	_	_	_	_
24-20	5582-5585	for	_	_	_	_
24-21	5586-5594	instance	_	_	_	_
24-22	5595-5596	,	_	_	_	_
24-23	5597-5600	the	abstract[250]|abstract[251]	giv[250]|giv[251]	coref|coref	24-26[0_250]|24-26[0_250]
24-24	5601-5610	structure	abstract[250]|abstract[251]	giv[250]|giv[251]	_	_
24-25	5611-5612	–	abstract[251]	giv[251]	_	_
24-26	5613-5621	activity	abstract[251]|abstract|abstract[254]	giv[251]|giv|new[254]	_	_
24-27	5622-5631	landscape	abstract[251]|abstract|abstract[254]	giv[251]|giv|new[254]	_	_
24-28	5632-5637	index	abstract[251]|abstract[254]	giv[251]|new[254]	_	_
24-29	5638-5639	(	_	_	_	_
24-30	5640-5644	SALI	object	new	_	_
24-31	5645-5646	)	_	_	_	_
24-32	5647-5650	has	_	_	_	_
24-33	5651-5655	been	_	_	_	_
24-34	5656-5664	proposed	_	_	_	_
24-35	5665-5667	to	_	_	_	_
24-36	5668-5676	evaluate	_	_	_	_
24-37	5677-5680	SAR	abstract|abstract[257]	giv|new[257]	_	_
24-38	5681-5691	smoothness	abstract[257]	new[257]	_	_
24-39	5692-5693	.	_	_	_	_
